Healthcarefromwww.theguardian.com7 months agoSales of Novo Nordisk's diabetes drugs including Ozempic slow sharplyNovo Nordisk's injectable diabetes drug sales, including Ozempic, have sharply declined due to competition and challenges in the market.
Intellectual property lawfromAbove the Law10 months agoPatenting Privation (Part III): Empowering Revenge - Above the LawThe FDA's lifting of the shortage declaration has curtailed bulk sales of competing diabetes medications, impacting telehealth revenues significantly.